Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
37°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
Activism
Animal Testing
Artificial Intelligence
Boeing 737
Brexit
Cannabis
Censorship
Climate
Coal
COVID-19
Criminal
Death
Debt Markets
Derivatives
Diversity
Economy
Electric Vehicles
Electricity Generation
Ethanol
Financial
Firearms
Fossil Fuels
Glyphosate
Harassement
Immigration
Information Security
Intellectual Property
Interest Rates
Labor
Layoff
Lead
Legal
Palm Oil
Pension
Political
Product Safety
Regulatory
Religion
Securities Market
Supply Chain
Tariff
Textiles
US Equities
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
IBD 50's Top Seed, ADMA, Just Rocketed On A New FDA Approval
April 28, 2025
Via
Investor's Business Daily
Exposures
Product Safety
Tickers
ADMA
LLY
Nephros Launches New S100 In-Line Microfilter
April 28, 2025
Via
TheNewswire.com
Exposures
Product Safety
Tickers
NEPH
Nephros Launches New S100 In-Line Microfilter
April 28, 2025
Via
NewMediaWire
Exposures
Product Safety
Tickers
NEPH
Novo Nordisk’s Weight-Loss Drug Wegovy Launched In Thailand, Marks Entry Into Southeast Asia
April 28, 2025
Via
Stocktwits
Exposures
Product Safety
Tickers
APIE
AVDE
HON
LLY
Down 36%, Is Moderna a Buy on the Dip?
April 28, 2025
Via
The Motley Fool
Exposures
COVID-19
Product Safety
Tickers
MRNA
PFE
Arlo Sinclair’s Art Turns Obsolete Tech into Cultural Mirror — Nostalgia, AI Anxiety and “Geek Luxury” Collide
April 27, 2025
Via
Press Release Distribution Service
Topics
Artificial Intelligence
Product Recall
Exposures
Artificial Intelligence
Legal
Product Safety
Novavax Tops Weekly Retail Buzz Spike Amid FDA Trial Drama, COVID-19 Vaccine Approval Hopes
April 27, 2025
Via
Stocktwits
Exposures
COVID-19
Product Safety
Tickers
NVAX
Elon Musk Said With Confidence 'I Know More About Manufacturing Than Anyone Alive'—Then the Cybertruck Rolled Out With 8 Recalls And A PR Mess
April 27, 2025
Via
Benzinga
Topics
Product Recall
Exposures
Legal
Product Safety
Tickers
TSLA
Where Will Altria Stock Be in 3 Years?
April 27, 2025
Via
The Motley Fool
Topics
Cannabis
Economy
World Trade
Exposures
Cannabis
Economy
Product Safety
Tickers
CRON
MO
PM
Roam And Grow: Transforming Family Travel with Practical Tips and Personal Experience
April 26, 2025
Via
Press Release Distribution Service
Topics
Product Recall
Exposures
Legal
Product Safety
From Burnout to $128K in 10 Months: Digital Marketer Kathryne LaBella Transforms Her Life and Business Using AI, Storytelling, and Strategy
April 26, 2025
Via
Press Release Distribution Service
Topics
Artificial Intelligence
Product Recall
Exposures
Artificial Intelligence
Legal
Product Safety
Kaplan Fox & Kilsheimer LLP is Investigating Potential Securities Law Violations Against ICU Medical, Inc. (ICUI)
April 26, 2025
Via
NewMediaWire
Exposures
Product Safety
Tickers
ICUI
Kaplan Fox & Kilsheimer LLP is Investigating Potential Securities Law Violations Against ICU Medical, Inc. (ICUI)
April 26, 2025
Via
TheNewswire.com
Exposures
Product Safety
Tickers
ICUI
Trump Signals Possible Support For Millionaires Tax Amid Election Concerns, Recalls George Bush's Promise: 'He Said Read My Lips And... Lost An Election'
April 26, 2025
Via
Benzinga
Topics
Government
Product Recall
Exposures
Legal
Political
Product Safety
Donna Matuizek Launches New Personal Website Showcasing Career, Insights, and Expertise
April 25, 2025
Via
Get News
Exposures
Product Safety
Why Biotech Stars Summit Therapeutics and BioNTech Plunged, Even as This Chinese Rival Surged Today
April 25, 2025
Via
The Motley Fool
Exposures
Product Safety
Tickers
BNTX
SMMT
What's Going On With Summit Therapeutics Stock On Friday?
April 25, 2025
Via
Benzinga
Exposures
Product Safety
Tickers
MRK
SMMT
Novo Nordisk Wins Legal Battle To Curb Unsafe Knockoff Versions Of Ozempic, Wegovy
April 25, 2025
Via
Benzinga
Exposures
Product Safety
Tickers
NVO
Summit Therapeutics Stock Slumps After Partner Akeso Gets FDA Nod For Cancer Drug: Retail’s Optimistic
April 25, 2025
Via
Stocktwits
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Product Safety
Tickers
NVDA
SMMT
VTI
XBI
Cowper Law LLP Defeats Medtronic's Motion for Summary Judgment in MiniMed Insulin Pump Litigation
April 25, 2025
Via
News Direct
Exposures
Product Safety
Tickers
MDT
Novo Nordisk Wins Another Legal Battle Against Compounding Of Wegovy, Ozempic: Retail’s Bullish
April 25, 2025
Via
Stocktwits
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
APIE
AVDE
NVO
FDA Puts VYNE Therapeutics Early-Stage Psoriasis Study On Hold
April 25, 2025
Via
Benzinga
Exposures
Product Safety
Tickers
VYNE
Gilead Sciences Q1 Earnings Surpass Analyst Expectations, But Revenue Falls Short Of Estimates: Retail’s Optimistic
April 25, 2025
Via
Stocktwits
Topics
Government
Stocks
Exposures
COVID-19
Political
Product Safety
Tickers
GILD
VOO
VTI
Years Ahead of the Curb: Gummi World’s Clean-Label Commitment Aligns with New FDA Synthetic Dye Ban
April 24, 2025
Via
PRUnderground
Exposures
Product Safety
Gilead (GILD) Q1 2025 Earnings Call Transcript
April 24, 2025
Via
The Motley Fool
Topics
Earnings
World Trade
Exposures
Financial
Product Safety
Tariff
Tickers
GILD
Kaplan Fox & Kilsheimer LLP is Investigating ICU Medical, Inc. (ICUI) for Potential Securities Law Violations
April 24, 2025
Via
TheNewswire.com
Exposures
Product Safety
Tickers
ICUI
Kaplan Fox & Kilsheimer LLP is Investigating ICU Medical, Inc. (ICUI) for Potential Securities Law Violations
April 24, 2025
Via
NewMediaWire
Exposures
Product Safety
Tickers
ICUI
DairyPill Launches “No Gassy Days” Starter Kit to Support Easier Dairy Digestion
April 24, 2025
Via
Get News
Exposures
Product Safety
Regulatory
Soligenix's HyBryte(TM) Shows 75% Response Rate In Skin Cancer Trial, Backed By FDA Funding
April 24, 2025
Via
NewMediaWire
Exposures
Product Safety
Tickers
SNGX
Soligenix's HyBryte(TM) Shows 75% Response Rate In Skin Cancer Trial, Backed By FDA Funding
April 24, 2025
Via
TheNewswire.com
Exposures
Product Safety
Tickers
SNGX
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.